SCHEDULE OF SUPPLEMENTAL BALANCE SHEET INFORMATION FOR LEASES (Details) - Maius Pharmaceutical Co. Ltd [Member] - USD ($) |
Mar. 31, 2025 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|---|---|---|---|
| Restructuring Cost and Reserve [Line Items] | |||
| Operating lease ROU assets | $ 56,132 | $ 75,687 | $ 27,023 |
| Current operating lease obligation | 39,736 | 40,106 | $ 22,087 |
| Total operating lease obligation | $ 39,736 | $ 40,106 |
| X | ||||||||||
- Definition Present value of lessee's discounted obligation for lease payments from operating lease. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of lessee's right to use underlying asset under operating lease. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|